|
End-of-day quote
OTC Bulletin Board
|
||
| - USD | - |
|
| 11-18 | Panacea Life Sciences Holdings and Benivita Inc. Launch Benivita PLSH | CI |
| 06/05/24 | Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Market Cap | 519K 447K 419K 383K 721K 49.6M 723K 4.97M 1.94M 25.04M 1.95M 1.91M 83.02M | P/E 2022 |
-0.11x | P/E 2023 | -0.31x |
|---|---|---|---|---|---|
| Enterprise Value | 22.05M 19M 17.81M 16.26M 30.63M 2.11B 30.73M 211M 82.46M 1.06B 82.78M 80.98M 3.53B | EV / Sales 2022 |
11.6x | EV / Sales 2023 | 10.1x |
| Free-Float |
-
| Yield 2022 * |
-
| Yield 2023 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.13% | -6.44% | +60.34% | +114.35% | 1,047B | |
| +0.85% | -0.81% | +51.29% | +63.71% | 646B | |
| -1.03% | -3.58% | +21.43% | +72.25% | 451B | |
| -1.46% | -4.50% | +37.80% | +37.01% | 355B | |
| -0.72% | -2.89% | +22.32% | +37.60% | 291B | |
| -1.19% | -2.21% | +1.53% | +11.51% | 252B | |
| -1.05% | -1.57% | +50.30% | +67.68% | 234B | |
| +0.08% | -1.78% | -17.64% | -54.11% | 203B | |
| -2.14% | -0.30% | +28.95% | +87.59% | 181B | |
| Average | -0.75% | -2.68% | +28.48% | +48.62% | 406.59B | |
| Weighted average by Cap. | -0.46% | -3.46% | +38.17% | +65.90% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.63M 1.4M 1.31M 1.2M 2.26M 155M 2.27M 15.6M 6.08M 78.49M 6.11M 5.98M 260M | 2.38M 2.06M 1.93M 1.76M 3.31M 228M 3.32M 22.86M 8.92M 115M 8.95M 8.76M 382M |
| Net income | -9.14M -7.88M -7.39M -6.74M -12.7M -874M -12.74M -87.64M -34.19M -441M -34.33M -33.58M -1.46B | -8.02M -6.91M -6.48M -5.91M -11.14M -766M -11.17M -76.83M -29.98M -387M -30.09M -29.44M -1.28B |
| Net Debt | 17.85M 15.38M 14.42M 13.17M 24.81M 1.71B 24.88M 171M 66.77M 861M 67.03M 65.57M 2.86B | 21.53M 18.55M 17.39M 15.88M 29.91M 2.06B 30.01M 206M 80.52M 1.04B 80.83M 79.07M 3.44B |
Employees
-
Sector
Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
